Corstiaan A. den Uil1,2, MD, PhD; Joost Daemen1, MD, PhD; Mattie J. Lenzen1, PhD; Anne-Marie Maugenest1, MSc; Linda Joziasse1, MSc; Robert Jan van Geuns1, MD, PhD; Nicolas M. Van Mieghem1*, MD, PhD
1. Department of Cardiology, Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands; 2. Department of Intensive Care Medicine, Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
Aims: Our aim was to test the feasibility and safety of the transfemoral PulseCath iVAC 2L (PulseCath, Amsterdam, The Netherlands).